Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovation to Boost European Markets for Wound-Closure Devices

By HospiMedica staff writers
Posted on 23 Nov 2006
Technologically innovative products can boost revenue growth in the European wound-closure devices markets.

A growing awareness among patients and surgeons about painless wound closure devices is supporting the use of products such as skin and tissue adhesives, which are safe and easy to use in comparison to conventional sutures and staples, while at the same time relieving the patient of the pain and subsequent removal of sutures. More...
Meanwhile, the rising number of plastic surgeries is promoting the use of synthetic absorbable sutures. These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

However, the rising demand for minimally invasive surgeries affects the growth prospects of the overall wound-closure markets. These surgeries not only reduce suture usage but also invariably have a dampening effect on the usage of mechanical wound closure devices and ligating clips, while associated reduced infection rates have substantially limited the need for wound strips.

To overcome these challenges, market participants should broaden the skin adhesives and absorbable suture applications in minimally invasive surgeries, since skin adhesives are currently used only during emergencies and for small cuts and incisions. At the same time, encouraging the use of synthetic absorbable sutures for closure of external wounds will boost unit sales.

"There has been a distinct shift towards painless wound closure with significant change occurring in certain segments such as absorbable sutures, skin adhesives and tissue sealants,” said Kezia Jasper, a research analyst with Frost & Sullivan. "These technological innovations will drive revenue growth and strengthen the future of the wound closure devices markets.”

Frost & Sullivan finds that the European markets for wound closure devices earned revenues of U.S.$217 million in 2005 and estimates this will reach $543 million in 2012.




Related Links:
Frost & Sullivan

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.